Lead Product(s) : Cetocire
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : NOVAVISION GROUP S.P.A | Jules Bordet Institute | GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil | Centre Hospitalier Universitaire Brugmann | Hôpitaux IRIS Sud
Deal Size : Inapplicable
Deal Type : Inapplicable
New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 28, 2019
Lead Product(s) : Cetocire
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : NOVAVISION GROUP S.P.A | Jules Bordet Institute | GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil | Centre Hospitalier Universitaire Brugmann | Hôpitaux IRIS Sud
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
